Clinical Trials Browser

Phase 1/2 × Interventional × Endostatins × Clear all

NCT01733589 2017-07-14

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung